Term Description

The response of the tumor to neoadjuvant treatment, such as chemotherapy, radiation therapy, or endocrine therapy.

LOINC Names Get Info

Fully-Specified Name
Lymph node response to neoadjuvant therapy:Find:Pt:Cancer specimen:Nom:CAP cancer protocols
Long Common Name
Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols
Short Name
LN resp neoadj therapy Ca spec CAP prot
Display Name
Lymph node response to neoadjuvant therapy CAP Nom (Cancer specimen)
Consumer Name Alpha Get Info
Lymph node response to neoadjuvant therapy, Cancer specimen

Part Model Get Info

  • Component
    Lymph node response to neoadjuvant therapy
    LP247952-7
    • Analyte
      Lymph node response to neoadjuvant therapy
      LP247952-7
      • Component Numerator
        Lymph node response to neoadjuvant therapy
        LP247952-7
        • Component Numerator Core
          Lymph node response to neoadjuvant therapy
          LP247952-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Find
    LP6813-2
  • Time
    Pt
    LP6960-1
  • System
    Cancer specimen
    LP247830-5
    • System Core
      Cancer specimen
      LP247830-5
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    CAP cancer protocols
    LP32200-5

Normative Answer List: LL4387-8

Source: College of American Pathologists
AnswerCodeScoreAnswer ID
No known presurgical therapyLA27236-1
No lymph nodes removedLA27241-1
No definitive response to presurgical therapy in metastatic carcinomaLA27242-9
Probable or definite response to presurgical therapy in metastatic carcinomaLA27243-7
No lymph node metastases. Fibrous scarring, possibly related to prior lymph node metastases with pathologic complete responseLA27244-5
No lymph node metastases and no prominent fibrous scarring in the nodesLA27245-2

Basic Attributes

Class
PATH
Type
Laboratory
First Released
Version 2.61
Last Updated
Version 2.61 (ADD)
Order vs. Observation
Observation

Member of these Panels

LOINCLong Common Name
85904-1Cancer pathology panel - Breast cancer specimen by CAP cancer protocols

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Uzlina lymfatická odpověď na neoadjuvantní terapii:Nález:Časový bod:Vzorek karcinomu:Nominální:Histopatologické protokoly CAP (College of American Pathologists)
el-GRGreek (Greece)Ανταπόκριση των λεμφαδένων στη νεοεπικουρική θεραπεία:Εύρεση:Pt:Δείγμα καρκίνου:Nom:Πρωτόκολλα CAP για τον καρκίνο
Synonyms: Nom PATH Pt Ανταπόκριση στη νεοεπικουρική θεραπεία Ανταπόκριση των λεμφαδένων στη νεοεπικουρική θεραπεία Δείγμα Δείγμα καρκίνου Εύρεση Καρκίνος Πρωτόκολλα CAP για τον καρκίνο
es-ESSpanish (Spain)respuesta del ganglio linfatic a terapia neoadyuvante:Hallazgo:Punto temporal:Muestra de cancer:Nom:Protocolo CAP de cáncer
es-MXSpanish (Mexico)Respuesta de los ganglios linfáticos a la terapia neoadyuvante:Hallazgo:Punto temporal:Espécimen de cáncer:Nominal:Protocolos de cáncer de CAP
it-ITItalian (Italy)Risposta di linfonodo a terapia neoadiuvante:Osservazione:Pt:Campione tumore:Nom:Protocolli cancro CAP
Synonyms: Campione di tumore Coinvolgimento del linfonodo Neoplasia maligna Osservazione Patologia Protocolli neoplasia maligna CAP Punto nel tempo (episodio)
zh-CNChinese (China)淋巴结对于新辅助疗法的反应:发现:时间点:癌标本:名义型:美国病理学家协会癌症方案
Synonyms: CAP 癌症方案;美国病理协会癌症方案 供检查用的材料;待检物;待试验物;样品;样本;试料;试样 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 发现是一个原子型临床观察指标,并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型,而对于叙述型文本之中所报告的发现,则可能是叙述型。;发现物;所见;结果;结论 受检物 对新辅助疗法(新辅助治疗)的反应(响应、应答);新辅助疗法(新辅助治疗)的效果 时刻;随机;随意;瞬间 样品 样本 淋巴结对于新辅助疗法(新辅助治疗)的反应(响应);新辅助疗法的淋巴结反应(响应、效果、疗效) 癌 癌(癌症、癌变)标本(样本、样品、试样) 累及淋巴结 试样

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=85349-9